212 related articles for article (PubMed ID: 25165815)
1. The GAP activity of type III effector YopE triggers killing of Yersinia in macrophages.
Wang X; Parashar K; Sitaram A; Bliska JB
PLoS Pathog; 2014 Aug; 10(8):e1004346. PubMed ID: 25165815
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Pyrin Dephosphorylation and Inflammasome Activation in Macrophages as Triggered by the
Medici NP; Rashid M; Bliska JB
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30602502
[TBL] [Abstract][Full Text] [Related]
3. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
[TBL] [Abstract][Full Text] [Related]
4. Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.
Rüssmann H; Panthel K; Köhn B; Jellbauer S; Winter SE; Garbom S; Wolf-Watz H; Hoffmann S; Grauling-Halama S; Geginat G
Infect Immun; 2010 Dec; 78(12):5138-50. PubMed ID: 20876292
[TBL] [Abstract][Full Text] [Related]
5. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence.
Black DS; Bliska JB
Mol Microbiol; 2000 Aug; 37(3):515-27. PubMed ID: 10931345
[TBL] [Abstract][Full Text] [Related]
6. Yersinia controls type III effector delivery into host cells by modulating Rho activity.
Mejía E; Bliska JB; Viboud GI
PLoS Pathog; 2008 Jan; 4(1):e3. PubMed ID: 18193942
[TBL] [Abstract][Full Text] [Related]
7. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
Sheahan KL; Isberg RR
mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
[TBL] [Abstract][Full Text] [Related]
8. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Viboud GI; Mejía E; Bliska JB
Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
[TBL] [Abstract][Full Text] [Related]
9. Yersinia outer protein YopE affects the actin cytoskeleton in Dictyostelium discoideum through targeting of multiple Rho family GTPases.
Vlahou G; Schmidt O; Wagner B; Uenlue H; Dersch P; Rivero F; Weissenmayer BA
BMC Microbiol; 2009 Jul; 9():138. PubMed ID: 19602247
[TBL] [Abstract][Full Text] [Related]
10. YopE of Yersinia, a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endothelial cells.
Andor A; Trülzsch K; Essler M; Roggenkamp A; Wiedemann A; Heesemann J; Aepfelbacher M
Cell Microbiol; 2001 May; 3(5):301-10. PubMed ID: 11298653
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of the YopE GTPase-activating protein (GAP) activity of Yersinia pseudotuberculosis.
Aili M; Isaksson EL; Hallberg B; Wolf-Watz H; Rosqvist R
Cell Microbiol; 2006 Jun; 8(6):1020-33. PubMed ID: 16681842
[TBL] [Abstract][Full Text] [Related]
12. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages.
Zhang Y; Murtha J; Roberts MA; Siegel RM; Bliska JB
Infect Immun; 2008 Sep; 76(9):4299-310. PubMed ID: 18591234
[TBL] [Abstract][Full Text] [Related]
13. CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection.
Zhang Y; Tam JW; Mena P; van der Velden AW; Bliska JB
PLoS Pathog; 2015 Oct; 11(10):e1005167. PubMed ID: 26468944
[TBL] [Abstract][Full Text] [Related]
14. Effector CD8+ T cells are generated in response to an immunodominant epitope in type III effector YopE during primary Yersinia pseudotuberculosis infection.
Zhang Y; Mena P; Romanov G; Bliska JB
Infect Immun; 2014 Jul; 82(7):3033-44. PubMed ID: 24799630
[TBL] [Abstract][Full Text] [Related]
15. Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach.
Sory MP; Boland A; Lambermont I; Cornelis GR
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11998-2002. PubMed ID: 8618831
[TBL] [Abstract][Full Text] [Related]
16. Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
Auerbuch V; Golenbock DT; Isberg RR
PLoS Pathog; 2009 Dec; 5(12):e1000686. PubMed ID: 19997504
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Yersinia Yop-effector delivery by translocated YopE.
Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the Yersinia pestis GTPase activator YopE.
Evdokimov AG; Tropea JE; Routzahn KM; Waugh DS
Protein Sci; 2002 Feb; 11(2):401-8. PubMed ID: 11790850
[TBL] [Abstract][Full Text] [Related]
19. Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta.
Schotte P; Denecker G; Van Den Broeke A; Vandenabeele P; Cornelis GR; Beyaert R
J Biol Chem; 2004 Jun; 279(24):25134-42. PubMed ID: 15060067
[TBL] [Abstract][Full Text] [Related]
20.
Sheppe AEF; Santelices J; Czyz DM; Edelmann MJ
Microbiol Spectr; 2021 Sep; 9(1):e0049621. PubMed ID: 34319170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
